DISPERSYN GERRIT (Chief Development Officer) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/16/2022ACC: 0001209191-22-010384
Officer· Chief Development Officer
Since Aug 2018
+126K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
126K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+126K
Price / share
—
Trade value
—
% of position
132.2%
2/15/2022
95.28K→221.28K
Total
Net shares
+126K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 2/15/2022 | A · Award | +126K | — | — | 132.2% | 95.28K | 221.28K |
| Total | +126K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported